Literature DB >> 227470

Activation of cyclic AMP-dependent protein kinases in human gut adenocarcinoma (HT 29) cells in culture.

J Marvaldi, P Mangeat, O A Ahmed, C Coeroli, G Marchis-Mouren.   

Abstract

Vasoactive intestinal peptide, secretin, catecholamines and prostaglandin E1 stimulate the accumulation of cyclic AMP in HT 29 cells (see Laburthe, M. et al. (1978) Proc. Natl. Acad. Sci. U.S. 75, 2772-2775). In the present work maximal activation of protein kinases has been obtained at similar or even lower concentrations of the effectors. Maximal stimulation also requires a phosphodiesterase inhibitor. Type I and type II cyclic AMP-dependent protein kinases from basal and stimulated cells have been characterized by DEAE-Sepharose chromatography. Further identidication of the kinase has been carried out by gel electrophoresis and assay of the enzymes in the gel slabs. Comparison of the radioautography patterns of high speed supernatant lysate from basal and stimulated cells shows: First, that one type I and two type II cyclic AMP-dependent protein kinases plus one or two major and two minor cyclic AMP-independent protein kinases are present in HT 29 cells. Second, that all three holoenzymes are fully dissociated upon maximal stimulation, while the activity of the independent kinases appears unchanged.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 227470     DOI: 10.1016/0304-4165(79)90365-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Photoaffinity labelling of the vasoactive-intestinal-peptide-binding site on intact human colonic adenocarcinoma cell line HT29-D4. Synthesis and use of photosensitive vasoactive-intestinal-peptide derivatives.

Authors:  J M Martin; H Darbon; J Luis; A el Battari; J Marvaldi; J Pichon
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

2.  Hormonal control of fructose 2,6-bisphosphate concentration in the HT29 human colon adenocarcinoma cell line. Alpha 2-adrenergic agonists counteract effect of vasoactive intestinal peptide.

Authors:  C Denis; H Paris; J C Murat
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

3.  Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.

Authors:  A Couvineau; M Rousset; M Laburthe
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.